---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-26-000161"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2026-08-10T20:08:59+00:00"
generated_at: "2026-08-10T20:10:08.210935+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q2 revenue up 38% to $753M; raises FY26 guidance to $3.1-3.3B

## Summary
- Q2 revenue $753.2M, +38% YoY; subscribers 2.89M, +19% YoY.
- Net loss $86.3M vs income $42.5M; gross margin 64% vs 76%; Adjusted EBITDA $60.3M.
- International revenue up 1,641% YoY to $131.4M, boosted by Eucalyptus acquisition.
- Raises FY26 revenue guidance to $3.1-3.3B and Adjusted EBITDA to $275-325M.
- Reaffirms 2030 targets of $6.5B revenue and $1.3B Adjusted EBITDA.

## SEC filing metadata
- accession: 0001773751-26-000161
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2026-08-10T20:08:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/0001773751-26-000161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375126000161/hims-20260810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-26-000161
- JSON: https://secwatch.observer/filing/0001773751-26-000161.json
- Plain text: https://secwatch.observer/filing/0001773751-26-000161.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.